CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, ...
Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.). Moderna said its booster candidates also ...
A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...
A Duke Health study on the Moderna booster shot reveals the shot showed signs of decreasing antibody levels against the omicron variant after six months. A Duke Health study on the Moderna booster ...
Moderna said in a statement Thursday their COVID-19 vaccine is 93 percent effective six months after receiving both vaccine doses, the Washington Post reported. The Washington Post said Moderna had ...
Moderna said on Monday its updated Covid-19 booster generated "significantly higher" neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier shot. The bivalent booster used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results